Literature DB >> 15057312

Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery.

Ching-Pin Chang1, Bradley W McDill, Joel R Neilson, Heidi E Joist, Jonathan A Epstein, Gerald R Crabtree, Feng Chen.   

Abstract

Congenital obstructive nephropathy is the principal cause of renal failure in infants and children. The underlying molecular and cellular mechanisms of this disease, however, remain largely undetermined. We generated a mouse model of congenital obstructive nephropathy that resembles ureteropelvic junction obstruction in humans. In these mice, calcineurin function is removed by the selective deletion of Cnb1 in the mesenchyme of the developing urinary tract using the Cre/lox system. This deletion results in reduced proliferation in the smooth muscle cells and other mesenchymal cells in the developing urinary tract. Compromised cell proliferation causes abnormal development of the renal pelvis and ureter, leading to defective pyeloureteral peristalsis, progressive renal obstruction, and, eventually, fatal renal failure. Our study demonstrates that calcineurin is an essential signaling molecule in urinary tract development and is required for normal proliferation of the urinary tract mesenchymal cells in a cell-autonomous manner. These studies also emphasize the importance of functional obstruction, resulting from developmental abnormality, in causing congenital obstructive nephropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057312      PMCID: PMC379320          DOI: 10.1172/JCI20049

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506.

Authors:  N A Clipstone; G R Crabtree
Journal:  Ann N Y Acad Sci       Date:  1993-11-30       Impact factor: 5.691

2.  Angiotensin induces the urinary peristaltic machinery during the perinatal period.

Authors:  Y Miyazaki; S Tsuchida; H Nishimura; J C Pope; R C Harris; J M McKanna; T Inagami; B L Hogan; A Fogo; I Ichikawa
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

3.  Embryonic development of the ureter and bladder: acquisition of smooth muscle.

Authors:  L A Baker; R A Gomez
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450

Review 4.  Regulation of the calmodulin-stimulated protein phosphatase, calcineurin.

Authors:  C B Klee; H Ren; X Wang
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

Review 5.  Neural control of renal function.

Authors:  G F DiBona; U C Kopp
Journal:  Physiol Rev       Date:  1997-01       Impact factor: 37.312

6.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

7.  Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin.

Authors:  D G Winder; I M Mansuy; M Osman; T M Moallem; E R Kandel
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

8.  Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory.

Authors:  I M Mansuy; M Mayford; B Jacob; E R Kandel; M E Bach
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

9.  Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins.

Authors:  J A Tumlin; J P Lea; C E Swanson; C L Smith; S S Edge; J S Someren
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

10.  Sonographic staging of the developmental status of mouse embryos in utero.

Authors:  Ching-Pin Chang; Lei Chen; Gerald R Crabtree
Journal:  Genesis       Date:  2003-05       Impact factor: 2.487

View more
  65 in total

1.  Functional obstruction: the renal pelvis rules.

Authors:  Cathy Mendelsohn
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 2.  Development of the kidney medulla.

Authors:  Renfang Song; Ihor V Yosypiv
Journal:  Organogenesis       Date:  2012-01-01       Impact factor: 2.500

3.  Angiotensin II regulates growth of the developing papillas ex vivo.

Authors:  Renfang Song; Graeme Preston; Ali Khalili; Samir S El-Dahr; Ihor V Yosypiv
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

4.  Absence of canonical Smad signaling in ureteral and bladder mesenchyme causes ureteropelvic junction obstruction.

Authors:  Piyush Tripathi; Yinqiu Wang; Adam M Casey; Feng Chen
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

5.  Calcineurin A-alpha but not A-beta is required for normal kidney development and function.

Authors:  Jennifer L Gooch; Juan J Toro; Rebecca L Guler; Jeffrey L Barnes
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 6.  Pathophysiology and treatment of ureteropelvic junction obstruction.

Authors:  Brent Williams; Basir Tareen; Martin I Resnick
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

7.  Smad signaling in the neural crest regulates cardiac outflow tract remodeling through cell autonomous and non-cell autonomous effects.

Authors:  Qunshan Jia; Bradley W McDill; Song-Zhe Li; Chuxia Deng; Ching-Pin Chang; Feng Chen
Journal:  Dev Biol       Date:  2007-08-31       Impact factor: 3.582

Review 8.  Genetic and developmental basis for urinary tract obstruction.

Authors:  Feng Chen
Journal:  Pediatr Nephrol       Date:  2008-12-16       Impact factor: 3.714

9.  Discs-large homolog 1 regulates smooth muscle orientation in the mouse ureter.

Authors:  Zhen X Mahoney; Bénédicte Sammut; Ramnik J Xavier; Jeanette Cunningham; Gloriosa Go; Karry L Brim; Thaddeus S Stappenbeck; Jeffrey H Miner; Wojciech Swat
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

Review 10.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.